- Report
- September 2023
- 173 Pages
Global
From €4157EUR$4,450USD£3,517GBP
- Report
- October 2023
- 180 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- February 2024
- 110 Pages
North America
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2022
- 439 Pages
Global
From €3335EUR$3,570USD£2,821GBP
- Book
- May 2021
- 224 Pages
- Book
- March 2014
- 144 Pages
- Book
- January 2014
- 728 Pages
- Book
- September 2013
- 152 Pages

Strabismus, also known as crossed eyes, is a condition in which the eyes do not align properly. It is a common condition in children, but can also occur in adults. It is usually treated with corrective lenses, such as glasses or contact lenses, or with surgery. In the optical market, strabismus is a major area of focus, as it affects a large portion of the population. Companies in the optical market are developing new technologies to diagnose and treat strabismus, such as computerized eye tracking systems and advanced imaging techniques. Additionally, companies are researching new treatments, such as botulinum toxin injections, to reduce the symptoms of strabismus.
Some companies in the strabismus market include Johnson & Johnson Vision Care, Inc., Bausch + Lomb, CooperVision, Inc., Essilor International, and Hoya Corporation. Show Less Read more